Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000902664-20-002857
Filing Date
2020-08-03
Accepted
2020-08-03 16:27:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 QIAGEN N.V. p20-1426sc13d.htm SC 13D 152148
  Complete submission text file 0000902664-20-002857.txt   153748
Mailing Address C/O MHD MANAGEMENT CO. 520 MADISON AVENUE, 30TH FLOOR NEW YORK NY 10022
Business Address C/O MHD MANAGEMENT CO. 520 MADISON AVENUE, 30TH FLOOR NEW YORK NY 10022 (212) 446-4000
DAVIDSON KEMPNER PARTNERS (Filed by) CIK: 0000928549 (see all company filings)

EIN.: 133393346 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D

Mailing Address HULSTERWEG 82 PL VENLO P7 5912
Business Address HULSTERWEG 82 PL VENLO P7 5912 31-77-35566-00
QIAGEN N.V. (Subject) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-54659 | Film No.: 201069546
SIC: 2836 Biological Products, (No Diagnostic Substances)